Humana (NYSE:HUM – Get Free Report) had its price objective dropped by research analysts at JPMorgan Chase & Co. from $593.00 to $575.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “neutral” rating on the insurance provider’s stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 13.90% from the company’s previous close.
A number of other equities research analysts have also issued reports on HUM. Royal Bank of Canada upped their target price on shares of Humana from $594.00 to $599.00 and gave the stock an “outperform” rating in a report on Thursday, November 2nd. Deutsche Bank Aktiengesellschaft raised their target price on shares of Humana from $468.00 to $628.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Sanford C. Bernstein decreased their target price on shares of Humana from $599.00 to $579.00 in a report on Tuesday, October 10th. StockNews.com upgraded shares of Humana from a “buy” rating to a “strong-buy” rating in a report on Friday, November 3rd. Finally, TD Cowen decreased their price objective on Humana from $616.00 to $613.00 and set an “outperform” rating on the stock in a report on Tuesday, August 15th. Four investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Humana has an average rating of “Moderate Buy” and a consensus price target of $590.28.
Humana Price Performance
Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings data on Wednesday, November 1st. The insurance provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.63. The company had revenue of $26.42 billion for the quarter, compared to analysts’ expectations of $25.57 billion. Humana had a return on equity of 21.03% and a net margin of 2.95%. Humana’s revenue was up 15.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.88 EPS. On average, equities analysts forecast that Humana will post 28.28 earnings per share for the current fiscal year.
Institutional Trading of Humana
A number of large investors have recently bought and sold shares of HUM. Sunbelt Securities Inc. purchased a new position in Humana during the first quarter worth about $28,000. WFA of San Diego LLC acquired a new position in Humana during the second quarter worth about $29,000. Gradient Investments LLC increased its holdings in Humana by 50.0% in the second quarter. Gradient Investments LLC now owns 69 shares of the insurance provider’s stock valued at $31,000 after buying an additional 23 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Humana by 81.0% during the 2nd quarter. Larson Financial Group LLC now owns 76 shares of the insurance provider’s stock valued at $34,000 after acquiring an additional 34 shares during the period. Finally, Baystate Wealth Management LLC increased its stake in Humana by 84.1% in the 2nd quarter. Baystate Wealth Management LLC now owns 81 shares of the insurance provider’s stock valued at $37,000 after purchasing an additional 37 shares in the last quarter. Institutional investors and hedge funds own 91.86% of the company’s stock.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
- Five stocks we like better than Humana
- What Is Dividend Yield and How Do You Calculate It?
- 3 ETFs that offer extreme diversification
- What Are Dividends? Buy the Best Dividend Stocks
- Williams-Sonoma is a steal for buy-and-hold investors
- Best Stocks Under $10.00
- A closer look at Warren Buffett’s latest surprise purchase
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.